Please assess the completion status of the following clinical trial:

Trial Title: Effect of Gabapentin on Orthopedic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing a hip arthroplasty, total knee arthroplasty, hip fracture repair American Society of Anesthesiologist rating I-III as determined by your anesthesiologist~Exclusion Criteria:~* Pregnancy and breast feeding~  * An allergy to any of the drugs to be used in the study (midazolam, Celecoxib, gabapentin, hydromorphone, bupivacaine)~ * History of a sleep disorder (Obstructive sleep apnea or daytime somnolence)~ * History of taking chronic narcotic pain medications or gabapentin~ * History of rheumatoid arthritis, a psychiatric disorder, or diabetes with impaired renal function~ * History of alcohol or illicit drug abuse.~ * History of a kidney or liver problem.~ * Inability or unwilling to use patient-controlled analgesia.~ * Unable to meet the criteria for removal of the endotracheal tube in the Operating Room~ * History of asthma, hives or an allergic type reaction following an aspirin or other NSAIDS drug such as Ibuprofen.~ * History of stroke or heart attack or thrombotic event within the past 3 months~ * Lactose intolerance~ * History of cardiac surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): Placebo one dose in the evening of surgery and post op day #1.
- Gabapentin (Type: ACTIVE_COMPARATOR): Gabapentin 400mg orally at 9pm on the evening of surgery and first day post operatively

Based on this trial design, predict the completion outcome and termination type (if applicable).